Surbhi Sidana, MD, presents the case of a 60-year-old with later relapsed/refractory multiple myeloma and discusses the evolving therapeutic landscape.
EP. 5: Treatment Sequencing in Patients who Progress Beyond CAR T in Early Relapse MM
July 25th 2024Focusing on a clinical scenario in which a patient receives early-line CAR T-cell therapy and relapses, Surbhi Sidana, MD, shares insights on treatment sequencing and the role of bispecific antibodies.
Watch